PinkDx

PinkDx is focused on improving the diagnostic outcome for women who have vague symptoms that could signal a gynecological cancer. Each year in the United States, an estimated 1.5 million women present with general symptoms, including bloating, pelvic pain, and abnormal bleeding, for which the cause is not clear. Over 100,000 women in the U.S. are ultimately diagnosed with a gynecological cancer each year. PinkDx is developing solutions to replace invasive, painful diagnostic procedures and mitigate the significant delays women and their doctors often face in obtaining answers.